Skip to main content

. 1988 Sep 3;297(6648):592–593. doi: 10.1136/bmj.297.6648.592-a

Severe reaction to diphosphonate: implications for treatment of Paget's disease.

A T Elliott ¹, T Murray ¹, R M Mackie ¹, J A Hunter ¹

PMCID: PMC1834493 PMID: 3139224

592

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cantwell B., Harris A. L. Single high dose aminohydroxypropylidene diphosphonate infusions to treat cancer-associated hypercalcaemia. Lancet. 1986 Jan 18;1(8473):165–166. doi: 10.1016/s0140-6736(86)92309-3. [DOI] [PubMed] [Google Scholar]
Ralston S. H., Alzaid A. A., Gardner M. D., Boyle I. T. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J (Clin Res Ed) 1986 Jun 14;292(6535):1549–1550. doi: 10.1136/bmj.292.6535.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
Ramos-Gabatin A., Orzel J. A., Maloney T. R., Murnane J. E., Borchert R. D. Severe systemic reaction to diphosphonate bone imaging agents: skin testing to predict allergic response and a safe alternative agent. J Nucl Med. 1986 Sep;27(9):1432–1435. [PubMed] [Google Scholar]

ACTIONS

RESOURCES